Neutropenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in neutropenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Thrombocytopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in thrombocytopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Progression‐free survival · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in progression‐free survival ‐ first‐line studies compared with placebo or standard of care (low certainty).
1 finding from 1 review
Progression‐free survival ‐ recurrent disease studies · glioblastoma in adults
Anti‐EGFR therapy may leads to lower progression‐free survival ‐ recurrent disease studies compared with placebo or standard of care (low certainty).
1 finding from 1 review
Depressive symptomatology (lower = less depressive symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Treatment non‐acceptability (higher = greater non‐acceptability): end‐of‐intervention · older people with depression
1 finding from 1 review
Depression remission · older people with depression
1 finding from 1 review
Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · older people with depression
1 finding from 1 review
Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Cosmetic appearance · participants with varicose veinsa
1 finding from 1 review
Complications ‐ DVT · participants with varicose veinsa
It is very uncertain whether foam sclerotherapy changes complications ‐ DVT compared with placebo (very low certainty).
1 finding from 1 review
Residual varicose veins · participants with varicose veinsa
It is very uncertain whether foam sclerotherapy changes residual varicose veins compared with placebo (very low certainty).
1 finding from 1 review
QoL · participants with varicose veinsa
1 finding from 1 review
Persistence of symptoms · participants with varicose veinsa
1 finding from 1 review
Recurrent varicose veins · participants with varicose veinsa
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical cure · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy showed no clear difference in clinical cure (symptomatic and clinical recovery by the end of… compared with placebo compared to placebo (moderate certainty).
1 finding from 1 review
Treatment failure (development of more severe signs and symptoms by the end of treatment) · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy may leads to lower treatment failure (development of more severe signs and symptoms by… compared with placebo compared to placebo (low certainty).
1 finding from 1 review
Relapse · children, aged 2 to 59 months, with WHO‐defined non‐severe pneumonia and wheeze
Antibiotic therapy showed no clear difference in relapse (children who were 'cured' but developed symptoms within… compared with placebo compared to placebo (low certainty).
1 finding from 1 review
Any measure of 'substantial' pain relief · rotator cuff disease
Shock wave therapy showed no clear difference in pain relief > 50%a compared with placebo (low certainty).
1 finding from 1 review
Pain Multiple scalese translated to VAS 0–10 (10 was severe pain)f · rotator cuff disease
Shock wave therapy showed no clear difference in pain Multiple scalese translated to VAS 0–10 (10 was severe pain)f compared with placebo (moderate certainty).
1 finding from 1 review